NewAmsterdam Pharma shareholders approve all proposals at 2024 AGM

NewAmsterdam Pharma Co N.V.

Quorum of 57.6M shares (64% of eligible) voted; all seven proposals passed.
Proposal 6 (reappointment of Louis Lange): 34.5M For, 13.2M Against, 357k Abstain.
Proposal 5 (appointment of William H. Lewis): 48.1M For, 10.7k Against, 1.2k Abstain.
Adopted 2023 annual accounts, discharged directors, ratified Deloitte as auditor for 2024.
Item 8.01 refiled a license agreement with Menarini omitted from 2023 10-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.